LICQX
Price
$18.42
Change
-$0.24 (-1.29%)
Updated
Nov 13 closing price
Net Assets
508.74M
VTIAX
Price
$40.28
Change
-$0.40 (-0.98%)
Updated
Nov 13 closing price
Net Assets
554.27B
Interact to see
Advertisement

LICQX vs VTIAX

Header iconLICQX vs VTIAX Comparison
Open Charts LICQX vs VTIAXBanner chart's image
Lord Abbett International Equity R2
Price$18.42
Change-$0.24 (-1.29%)
VolumeN/A
Net Assets508.74M
Vanguard Total Intl Stock Index Admiral
Price$40.28
Change-$0.40 (-0.98%)
VolumeN/A
Net Assets554.27B
LICQX vs VTIAX Comparison Chart in %
View a ticker or compare two or three
VS
LICQX vs. VTIAX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LICQX is a StrongBuy and VTIAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTIAX has more cash in the bank: 554B vs. LICQX (509M). VTIAX pays higher dividends than LICQX: VTIAX (2.70) vs LICQX (0.86). LICQX was incepted earlier than VTIAX: LICQX (18 years) vs VTIAX (15 years). LICQX (1.32) is less costly to investors than VTIAX (0.09). LICQX is a more actively managed with annual turnover of: 89.00 vs. VTIAX (3.00). LICQX has a lower initial minimum investment than VTIAX: LICQX (0) vs VTIAX (3000). VTIAX annual gain was more profitable for investors over the last year : 25.12 vs. LICQX (23.33). VTIAX return over 5 years is better than : 39.59 vs. LICQX (30.71).
LICQXVTIAXLICQX / VTIAX
Total Expense Ratio1.320.091,467%
Annual Report Gross Expense Ratio1.320.091,467%
Fund Existence18 years15 years-
Gain YTD29.40428.912102%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets509M554B0%
Annual Yield % from dividends0.862.7032%
Returns for 1 year23.3325.1293%
Returns for 3 years51.7449.28105%
Returns for 5 years30.7139.5978%
Returns for 10 years66.1779.3583%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACRV2.280.21
+10.14%
Acrivon Therapeutics
MRNA26.710.30
+1.14%
Moderna
EGHAU10.55N/A
N/A
EGH Acquisition Corp.
RAMP30.46-0.42
-1.36%
LiveRamp Holdings
IMRX6.62-0.12
-1.78%
Immuneering Corp